PHARMACEUTICAL PREPARATIONS CONTAINING ALBUMEN

Brand Owner Address Description
O2 FACTOR Obschestvo s ogranichennoj otvetstvennost'yu "Laboratoriya sovremennogo zdorov'ya" ul. Khimzavodskaia, 11/20 Russian Federation Pharmaceutical preparations containing albumen for the treatment of viral infections; antiseptics; bacterial preparations for medical and veterinary use; analgesic balms for medical purposes; biocides; biological preparations for medical purposes; pharmaceutical preparations for use in aiding digestion; disinfectants for hygiene purposes; ferments for pharmaceutical purposes; fumigating incense sticks; germicides; herbs teas for medicinal purposes; liniments; medicated skin lotions for pharmaceutical purposes; medicinal herbs in dried or preserved form; herbal infusions for medicinal purposes; herbal mud packs for medicinal purposes; medicinal castor oils; herbal roots for medicinal purposes; medicated mouthwashes for medical purposes; pharmaceutical preparations for the treatment of nerve disorders; organotherapy pharmaceutical preparations for the treatment of skin disorders; pharmaceutical preparations for skin care; pharmaceutical preparations for treating dandruff; pharmaceutical preparations composed of trace elements for human and animal use to treat skin conditions; pharmaceutical preparation remedies for perspiration; sanitary towels used as sanitizing wipes; sea water for medicinal bathing; medicated serums for use in treating skin conditions; styptic pencils; medicated therapeutic preparations for the bath for medical purposes; tissues impregnated with pharmaceutical lotions to treat skin conditions; medicated tonics to treat digestive problems; multi-vitamin preparations;O TWO FACTOR;O2;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The invention provides compositions, pharmaceutical preparations and methods for inhibition of cystic fibrosis transmembrane conductance regulator protein (CFTR) that are useful for treating secretory diarrhea. The compositions and pharmaceutical preparations of the invention may comprise one or more thiazolidinone compounds, and may additionally comprise one or more pharmaceutically acceptable carriers, excipients, and/or diluents.